Valuation: Numinus Wellness Inc.

Market Cap 19.82M 14.34M 12.3M 11.49M 10.54M 1.37B 20.14M 136M 53.07M 687M 53.84M 52.67M 2.27B P/E 2023
-1.72x
P/E 2024 -0.48x
Enterprise Value 19.89M 14.39M 12.35M 11.53M 10.58M 1.38B 20.22M 136M 53.27M 690M 54.04M 52.87M 2.28B EV / Sales 2023
2.21x
EV / Sales 2024 2.48x
Free-Float
98.26%
Yield 2023 *
-
Yield 2024 -
1 day-9.27%
1 week-8.82%
Current month+17.53%
1 month-7.18%
3 months+17.92%
6 months+5.69%
Current year+20.67%
1 week 0.03
Extreme 0.0303
0.04
1 month 0.02
Extreme 0.024
0.05
Current year 0.01
Extreme 0.0055
0.06
1 year 0.01
Extreme 0.0055
0.06
3 years 0.01
Extreme 0.0055
0.18
5 years 0.01
Extreme 0.0055
0.82
10 years 0.01
Extreme 0.0055
1.93
Manager TitleAgeSince
Chief Executive Officer - 2025-01-22
Director of Finance/CFO - 2025-02-17
Chief Tech/Sci/R&D Officer - 2022-06-09
Director TitleAgeSince
Chairman - 1962-06-25
Director/Board Member - 2020-05-14
Director/Board Member 69 2019-01-27
Date Insider Type Main position Quantity % Market Cap.
2/28/24 Buy

Director

208,000 0.0769%
12/27/23 Buy

Director

100,000 0.0376%
12/27/23 Buy

Director

100,000 0.0376%
Change 5-day change 1-year change 3-year change Capi.($)
-9.27%-8.82% - - 11.6M
Average -9.27%
Weighted average by Cap. -9.27%

Financials

2023 2024
Net sales 23.18M 16.77M 14.39M 13.44M 12.33M 1.6B 23.56M 159M 62.08M 804M 62.98M 61.61M 2.66B 4.17M 3.02M 2.59M 2.42M 2.22M 288M 4.24M 28.51M 11.16M 145M 11.33M 11.08M 478M
Net income -30.26M -21.89M -18.78M -17.54M -16.09M -2.09B -30.75M -207M -81.03M -1.05B -82.21M -80.42M -3.47B -19.64M -14.21M -12.19M -11.39M -10.45M -1.36B -19.97M -134M -52.61M -681M -53.37M -52.21M -2.25B
Net Debt -1.38M -999K -857K -800K -734K -95.46M -1.4M -9.44M -3.7M -47.88M -3.75M -3.67M -158M 74.32K 53.78K 46.13K 43.07K 39.52K 5.14M 75.54K 508K 199K 2.58M 202K 198K 8.52M
Logo Numinus Wellness Inc.
Numinus Wellness Inc. is a mental healthcare company. It focuses on advancing traditional and behavioral health treatments, including safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and provides clinical research management services to academic institutions and biotechnology companies. Practitioner Training develops tailored education and training for research and drug development organizations to support clinical trials and commercialization efforts. Clinic network includes wellness clinics, which is engaged in providing clinical services from psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management. It is the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Employees
-
Date Price Change Volume
26-08-19 US$0.0362 -9.27% 392,063
26-08-18 US$0.0399 +8.13% 18,359
26-08-17 US$0.0369 +0.54% 67,492
26-08-14 US$0.0367 +21.12% 32,620
26-08-13 US$0.0303 -23.68% 107,051

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NUMIF Stock